Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder CancerNiv Milbar, Trinity J. Bivalacqua, Max Kates et al.|Bladder Cancer|2017Cited by 86
Regenerative and engineered options for urethroplastyFilippo Pederzoli, Nikolai A. Sopko, Trinity J. Bivalacqua et al.|Nature Reviews Urology|2019Cited by 52
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02Andrea Necchi, Francesco Montorsi, Alberto Martini et al.|Urologic Oncology Seminars and Original Investigations|2021Cited by 42
Surgical Factors Associated With Male and Female Sexual Dysfunction After Radical Cystectomy: What Do We Know and How Can We Improve Outcomes?Filippo Pederzoli, Trinity J. Bivalacqua, Jeffrey Campbell et al.|Sexual Medicine Reviews|2018Cited by 38
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping reviewTiago Costa de Pádua, Andrea Necchi, Marco Moschini et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 29